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DNA was extracted from the peripheral blood of a seropositive, PCR-positive, BLV-infected Holstein cow (No. 38) from
Argentina. The DNA was amplified via PCR with a series of overlapping primers encompassing the entire BLV proviral DNA.
The amplified BLV ARG 38 DNA was cloned, sequenced, and compared phylogenetically to three other full-length BLV
sequences. Characterization of its deduced proteins and its relationship to other members of the PTLV/BLV genus of
retroviruses are discussed. © 2000 Academic PressBovine leukemia virus (BLV) is an infectious agent of
cattle that can cause lymphomas and benign disorders
that, directly or indirectly, have a financial impact on the
cattle industry (Ferrer, 1980; Brenner et al., 1989; Burny et
l., 1990). It is estimated that more than 10 and 30% of the
airy and beef cattle in the United States and Argentina,
espectively, are infected with BLV (Ferrer, 1980; Brenner
t al., 1989; Trono et al., 1999). BLV, together with the
rimate T-cell leukemia/lymphoma viruses (PTLV), form a
eparate genus of retroviruses that exhibit in vivo lym-
hotropism and are characterized by the transforming
roperty of a unique virus regulatory protein, Tax, that
an transactivate both viral and cellular genes (for review
ee Poiesz, 1995). We are engaged in several in vitro and
n vivo studies on the biology and epidemiology of BLV in
commercial herd of Holstein dairy cattle maintained
ear the Facultad de Ciencias Veterinarias de Tandil,
rgentina (FCV-UNCP BA). We decided to fully sequence
strain of BLV infecting this herd in order to compare it
hylogenetically to other members of its genus and to
ave a structural blueprint for correlation with observed
n vitro and in vivo functional phenomena.
RESULTS
equence of BLV ARG 38
Quantitative analyses indicated that there were ap-
roximately 5000 copies of BLV pol DNA per mg of cow
o. 38 peripheral blood leukocyte DNA. PCR amplifica-
ion and Southern blot hybridization were successful for
ach of the primer pair/probe groups shown in Fig. 1.
1 To whom correspondence and reprint requests should be ad-
ressed at the Department of Medicine, SUNY Upstate Medical Uni-
ersity, 750 E. Adams Street, Syracuse, NY 13210.
379Some primer pair/probe systems not listed were not
successful, usually because of BLV ARG 38-specific mu-
tations (data not shown). The complete sequence of BLV
ARG 38 was obtained from these amplified products
(GenBank Accession No. AF257515). No variability was
observed among the many overlapping clones se-
quenced from each of the regions shown, indicating that
cow No. 38 was infected with one unique strain of BLV.
Comparative analyses indicate that BLV ARG 38 is
approximately 95.1% homologous to BLV A from Austra-
lia, 95.6% to BLV GAGA from Belgium, and 95.9% to BLV
CG from Japan. Phylogenetic analyses (Fig. 2) confirm
that it is most homologous to BLV CG from Japan and
markedly divergent from the primate T-cell lymphoma/
leukemia viruses.
The availability of now a fourth fully sequenced BLV
strain allows for a more precise estimate of the node of
separation (node A in Fig. 2) among the PTLV. In the
gag/pol sequences compared, the PTLV-I [human and
simian T-cell lymphoma/leukemia viruses type I (HTLV-I
and STLV-I)] diverge from a separate group comprising
the PTLV-II [human and simian T-cell lymphoma/leuke-
mia viruses type II (HTLV-II and STLV-II)] and primate
T-cell lymphoma/leukemia viruses, long (PTLV-L). Inter-
estingly, if one measures the distance of each PTLV
strain from node A, it is apparent that the PTLV-II and
PTLV-L have diverged at approximately 1.5 times the rate
of the PTLV-I [mean of 1367 bases (6135) vs mean of 805
bases (630); P , 0.001].
Comparison of the LTR of BLV ARG 38 with that of the
other full-length BLV sequences is shown in Fig. 3. It
contains the RNA transcription promoter and enhancer
elements, polyadenylation signal, and REX response el-
ement typical of BLV. The only change of possible con-
sequence in BLV ARG 38 is a G Ü A at base 58 in the
0042-6822/00 $35.00
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380 DUBE ET AL.middle of the first enhancer element. The tRNA proline
primer binding site is also absolutely conserved.
While the BLV gag region is highly conserved, it is
apparent (Fig. 4) that there are two different peptide
sequences preferred for p15 and p24. The BLV CG strain
is markedly divergent over the last 40 amino acids of its
p24 protein. Whether this is a real observation or the
result of sequencing error (Fig. 5) and whether these
changes have functional consequences are unknown.
FIG. 1. A diagram of BLV proviral DNA showing its various functiona
the BLV A isolate from Australia (Coulston et al., 1990). They represent
urther below the diagram indicate the bases of the overlapping plus- a
FIG. 2. A maximum parsimony distance tree comparing the phylo-
genetic relationships of approximately 4.2 kb of gag and pol sequences
f the various BLV and PTLV strains shown. The relative distances are
hown on the x axis and the bootstrap values for those branches are
s indicated. The bar in the lower-left-hand corner shows a length
qual to 500 unique base changes. It is equivalent to an actual se-muence divergence of approximately 12%.However, this is a highly conserved, immunodominant
region in the BLV/PTLV genus, suggesting that such a
change would have fundamental biological conse-
quences (Rice et al., 1987; Perzova et al., 2000). The
deduced protease proteins were also highly conserved
among the four BLV strains (Fig. 4), except for the fact
that the published sequence of BLV GAGA contains an
insertion that causes a frame shift at amino acid (aa) 150
and eliminates a stop codon at amino acid 169 (Fig. 5).
Again, it is highly likely that this difference may be due to
a sequencing error in BLV GAGA. The deduced RNase,
reverse transcriptase, and integrase amino acids en-
coded by the pol gene of all four BLV strains are highly
conserved (Fig. 4), with there being again two slightly
different peptide sequences among the four strains.
The env leader peptides and the transmembrane gp30
env proteins of all four strains are also highly conserved,
as are the gp51 surface env proteins of three of the
strains (Fig. 4). BLV ARG 38, however, demonstrates
significant divergence at the carboxyl terminus of its
gp51 env protein. This is the transmembrane hydropho-
bic region of gp51, believed to be responsible for anchor-
ing the surface env protein in the viral membrane (Kett-
man et al., 1994). Hydrophobicity plots (data not shown)
indicate that this region of BLV ARG 38 would be more
hydrophobic than the other three strains and theoreti-
cally more stably embedded in the viral envelope.
All N-linked glycosylation sites and cysteine residues
in both env proteins are conserved, as are important
functional domains, including the putative cell surface
receptor binding sites and neutralizing domains on the
surface gp51 env protein, the peptide region in gp51 that
induces a CD81 cytotoxic T-cell response in the host
ow, the highly immunogenic epitope GD21 that is con-
erved in all members of the PTLV/BLV genus, the tet-
apeptide WAPE (aa 222–225 in Fig. 4) that has been
hown to be critical for infection, and the residues P and
(aa 210 and 211 in Fig. 4) that have been shown to
nduce T-helper proliferative responses in cattle (Kett-
tructural genes. The bases shown directly above and below are from
d or beginning of important regions of the BLV genome. The numbers
us-strand oligonucleotide primers used to amplify the BLV Arg38 DNA.l and s
the enann et al., 1994; Perzova et al., 2000; Rice et al., 1987).
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381GENOMIC SEQUENCE OF BLV STRAINComparison of the four deduced BLV Tax and Rex
proteins again demonstrates what is probably the result
of sequencing errors in BLV A (Figs. 4 and 5). With that
noted, there is marked conservation of the Tax and Rex
peptides. The two peptide sequences evident in aa
78–84 of the Tax protein occur in a region that has been
shown to be critical for Tax transactivation (Sakurai et al.,
1991).
The deduced amino acids from two peptides, GIV and
RIIIORF, which are translated from alternatively spliced
mRNA’s known to be expressed in BLV-infected cells, are
also shown in Fig. 4. The expression of one of these, GIV,
has been associated with persistent B-cell lympocytosis
(PBL) in infected cattle (Alexandersen et al., 1993). It is
interesting to note that the BLV ARG 38 GIV protein is the
most divergent and that cow No. 38 exhibits PBL. The
changes in BLV ARG 38 GIV would make its leader
peptide more hydrophobic, eliminate a serine protease
cleavage site, and cause a F Ü S amino acid change in
the myb homologous site relative to the consensus se-
uence.
DISCUSSION
BLV is a member of a genus of pathogenic retroviruses
hat cause a variety of malignant and autoimmune dis-
ases in cattle, humans, and nonhuman primates. While
uch is known regarding the clinical sequelae of BLV
nfection in domesticated cattle, little is known of its
enetic diversity, epidemiology, and disease association
mong bovids around the planet. Because the human
etroviruses HTLV-I and HTLV-II share a common ances-
or with BLV, understanding this genetic diversity and its
iological implications is not an interest just of veterinary
edicine.
The sequence of the BLV ARG 38 strain presented
erein brings the number of worldwide complete
enomic BLV sequences to a total of four. Upon compar-
son with the other three sequences, BLV ARG 38 was
hown to be approximately 5% divergent from each of
hem. Comparison of their deduced amino acid se-
uences has clarified some differences in predicted pep-
ides, which are probably due to minor sequencing er-
ors in the BLV A, BLV GAGA, and BLV CG sequences. In
lmost all of these instances, there has been an insertion
r deletion of a base in a region of multimers of that base
Fig. 5). Beyond the clarification of these discrepancies,
owever, there are differences among the various strains
f unknown biologic significance. In particular, the BLV
RG 38 strain would be predicted to have a more hydro-
hobic gp51 env transmembrane region and GIV leader
eptide than the other strains. These data should provide
BOX and GATAA (PROMT) box promoters of RNA transcription, the
polyadenylation site (PAS), the CAP site, and the tRNA proline primerFIG. 3. Long termnial repeat nucleic acid sequences of BLV ARG 38
compared to three other published BLV strains: BLV GAGA, BLVA, and
BLVCG (Sagata et al., 1985; Rice et al., 1987; Coulston et al., 1990). The
consensus sequence is shown at the bottom of each alignment. A hash
is shown in the consensus sequences in areas of nonagreement. A
bullet indicates homology with the consensus sequence, while the
nucleic acid substitutions are as indicated. The U3, R, and U5 regionsbinding sites are as shown.
Cs
b
a
a
P
(
c
d
t
e
t
N
p
p
e
c
s
t
i
a
p
b
t
s
382 DUBE ET AL.a more accurate basis for comparison of structure and
function relationships and for BLV detection and vaccine
strategies.
An additional complete genome of BLV also provides
further data for phylogenetic analyses. As shown in Fig.
2, the BLV and PTLV evolved from a common ancestor,
presumably many tens, if not hundreds, of thousands of
years ago. What is readily apparent is that the diver-
gence of the BLV strains from their node of separation
(about 5%) falls far short of that observed among the
PTLV (up to approximately 37%). If one assumes that time
is constant and that mutation rates are relatively con-
stant, one would expect to observe more diversity on the
BLV branch of the cladogram. It is highly likely that many
other variant BLV strains, with unknown pathogenic ca-
pabilities, are to be found on the planet. Recently defined
detection strategies for detecting all members of the
BLV/PTLV genus should prove useful in the search for
such variants (Perzova et al., 2000).
MATERIALS AND METHODS
ow 38
Peripheral blood leukocytes were obtained from a Hol-
tein (Holando–Argentino) dairy cow (No. 38) that had
een proven to be infected with BLV in 1995 by serology
ssays, which included ELISA and Western blot assay for
ntibodies to BLV p24 gag and gp51 env proteins, and by
CR assays for the BLV pol gene as previously described
Dube et al., 1997). Cow 38 is still alive and remains
ompletely healthy with no evidence of lymphoma, but
oes manifest a peripheral blood leukocytosis. Short-
erm cultures of cow No. 38 peripheral blood leukocytes
xpressed BLV p24 gag protein as measured by a quan-
itative capture ELISA (Gupta and Ferrer, 1981).
ucleic acid studies
DNA was organically extracted from fresh cow No. 38
eripheral blood leukocytes and amplified via PCR, as
reviously described (Dube et al., 1997). Two micrograms
FIG. 4. Deduced amino acid sequences of the various proteins of
BLV ARG 38 compared to three other published BLV strains: BLVGAGA,
BLVA, and BLVCG. The consensus sequences are shown at the bottom
of each alignment. A dash is shown in the consensus sequences in
areas of nonagreement. The bullets show areas of homology with the
consensus sequence while the amino acid substitutions are as indi-
cated and deleted amino acids are indicated by the symbol ( - ). The
nds of the various proteins are indicated by the up arrow (d). Stop
odons are indicated by asterisks (*). Only a portion of the BLVA Tax is
hown, and the rest is indicated by the symbol (;). In the Env proteins
he N-linked glycosylation sites are shown in bold, while the neutral-
zing domains (ND), the transmembrane hydrophobic region (TMHR),
nd various immunostimulatory epitopes are as shown. In the GIV
rotein the two putative cellular protease cleavage sites are indicated
y an inverted triangle () and the amino acid myb-like motif (MYB) and
he arginine-rich nucleus targeting RNA-binding region (ARNTRB) are
hown.
FIG. 4—Conti
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385GENOMIC SEQUENCE OF BLV STRAINof each DNA sample was amplified with one of the
overlapping BLV primer sets shown in Fig. 1. The ampli-
fied products were detected by Southern blot hybridiza-
tion using 32P-labeled oligonucleotide probes located
etween the flanking primers. Amplified specific prod-
cts were cloned into a TA cloning vector (Invitrogen,
an Diego, CA) and sequenced using an automated
equencer (Applied Biosystems, Foster City, CA). Several
lones were sequenced for each primer pair and se-
uences were obtained for both strands of DNA. The
verlapping sequences were used to obtain the BLV ARG
8-specific regions homologous to the primers and to
ouble check the accuracy of the sequences. Sequences
ere aligned (Needleman and Wunsch, 1970), and a
aximum parsimony program (Swofford, 1991) was used
o compare new and previously published retroviral se-
uences. Both distance and bootstrap (100 replications)
rees were generated. The other strains included BLV A;
LV GAGA; BLV CG; HTLV-I ATK; HTLV-I ATL; HTLV-I EL;
TLV-I TAN 90; STLV-I MACA; HTLV-II MOT; HTLV-II
FIG. 5. Alignments of nucleic acids within the p24 gag, protease, and
Tax/Rex regions of the BLV genome that contain deletions and/or
insertions that distort the reading frames in some of the BLV strains
(see Fig. 4). The numbers at the top of the sequences indicate the
terminal bases according to the BLV A sequence. Conserved se-
quences are indicated by a bullet (c) and deletions are indicated by a
hyphen ( - ). The reading frames are shown for the BLV Arg38 strain,
which we believe to be the correct reading frame (Fig. 4). The Tax
reading frame, which is as shown, overlaps with the Rex reading frame.
As can be seen, a deletion of a C at base 1441 in the BLV Cg strain
causes a frame shift in the translation of gag p24. Through a series of
subsequent deletions and insertions, the sequence returns to the
proper reading frame by base 1566. Similarly, BLV Gaga contains an
extra base in its protease gene, which distorts its reading frame relative
to the other three strains. Finally, BLV A contains an inserted A after
base 7474, which alters both the Tax and Rex reading frames.AYAPO; HTLV-II NRA; HTLV-II G2; STLV-II; STLV-II pp;nd PTLV-L; the sequences of these were obtained from
enBank.
The number of each unique base of each PTLV-I,
TLV-II, and PTLV-L strain from node A (Fig. 2) was
alculated, and the means and standard deviations of
he PTLV-I vs the PTLV-II and the PTLV-L distances were
alculated and analyzed statistically using the Student t
est. Hydrophobicity plots of the BLV ARG 38 and the
onsensus gp51 env proteins were generated using the
etwork Protein Sequence @ nalysis program (Poˆle Bio-
nformatique Lyonnais).
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